Impact of Forearm Free Flap in Orbital Exenteration Reconstruction (REXOR)
Apport du Lambeau Libre antébrachial Dans la Reconstruction Post-exentération
Orbital exenteration is the en bloc removal of the entire orbital contents. This mutilating surgical technique is reserved for the management of certain malignant orbito-palpebral tumors or those that secondarily invade the orbit.
Several types of exenteration have been described, more or less extended to the adjacent structures, with sometimes mixed ENT-neurosurgical approaches for lesions invading the endocranium and causing large losses of substance.
Different surgical reconstruction techniques have been developed over the years, from spontaneous epithelialization to free osteo-muscular flap and temporal muscle transpositions.
Reconstruction after exenteration is essential to limit the sequelae and to allow the patient who has undergone this trauma to regain social interactions, a quality of life and an optimal self-image.
The use of an antebrachial free flap would allow a faster healing and thus an earlier rehabilitation.
The main objective of the study was to compare the morbidity of the antebrachial free flap with that of the temporal flap during exenteration and the rate of fitting of patients with epitheses.
調査の概要
状態
条件
詳細な説明
Reconstruction after exenteration is essential to limit the after-effects and to allow the patient who has suffered this trauma to regain social interaction, quality of life and self-image.
The principal investigator hypothesize that reconstruction with a free antebrachial flap can improve the quality of life of an exentered patient while maintaining a low risk of intra- and post-operative morbidity.
The aim of such a study will therefore be to provide assistance to both surgeons and patients, as to the choice of the technique of orbital reconstruction, by highlighting objectively and subjective evidence of the benefits of one technique over the other.
The patients included in this study will have to answer two questionnaires, submitted by post or directly at the follow-up consultation. This study therefore falls within the framework of studies of minimal or moderate risk studies. They will be informed by telephone interview beforehand or directly in the consultation about the method of writing the questionnaires and their content.
研究の種類
入学 (予想される)
連絡先と場所
研究連絡先
- 名前:Antoine DUBRAY-VAUTRIN, MD
- 電話番号:+33144324535
- メール:Antoine.DubrayVautrin@curie.fr
研究場所
-
-
-
Paris、フランス、75005
- 募集
- Institut Curie
-
コンタクト:
- Adeline GIGANTI, Ph.D
- 電話番号:+33147112355
- メール:adeline.giganti@curie.fr
-
コンタクト:
- Antoine DUBRAY-VAUTRIN, MD
- 電話番号:+33144324535
- メール:Antoine.DubrayVautrin@curie.fr
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Patients who were exentered and then reconstructed by free antebrachial flap or temporal muscle flap muscle flap at the Institut Curie Paris, between January 2005 and December 2020.
Exclusion Criteria:
- Legally protected patients
- Patients unable to give consent.
研究計画
研究はどのように設計されていますか?
デザインの詳細
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Temporal muscle flap patient questionnaire.
時間枠:Baseline
|
A questionnaire of quality of life and side effects related to surgery for patients having a temporal muscle flap reconstruction (13 questions with binary or numerical answers)
|
Baseline
|
|
Antebrachial flap patient questionnaire
時間枠:Baseline
|
A questionnaire of quality of life and side effects related to surgery for patients having antebrachial flap reconstruction (17 questions with binary or numerical answers)
|
Baseline
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Antoine DUBRAY-VAUTRIN, MD、Institut Curie
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- IC-2020-19
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。